VORSETUZUMAB BETA
UNII Y2WZ63QGT3

Substance Identification & Data

This profile provides standardized clinical and technical data for Vorsetuzumab Beta, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Y2WZ63QGT3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3055304-29-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Y2WZ63QGT3

CAS Registry Number

3055304-29-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VORSETUZUMAB BETA

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

13885

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vorsetuzumab Beta. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VORSETUZUMAB BETA

Common Names & Synonyms

H-GAMMA1 HEAVY CHAIN (1-448) (VH (HOMO SAPIENS IGHV1-2*02 (86.7%) E51>K (46) -(IGHD) -IGHJ4*01 (92.3%) L123>T (113), CDR-IMGT (8.8.11) (26-33.51-58.97-107)) (1-118) -HOMO SAPIENS IGHG1*01 (100%) G1M17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (215) (119-216), HINGE 1-15 (217-231), CH2 (232-341), CH3 D12 (357), L14 (359) (342-446), CHS (447-448)) (119-448)), (221-218')-DISULFIDE WITH L-KAPPA LIGHT CHAIN (1'-218') (V-KAPPA MUSMUS/HOMSAP (MUS MUSCULUS IGKV3-12*01 (84.8%) -IGKJ1*01 (83.3%) G120>Q (104'), L124>V (108')/HOMO SAPIENS IGKV4-1*01 (79.2%) -IGKJ1*01 (100%), CDR-IMGT (10.3.9) (27'-36'.54'-56'.93'-101')) (1'-111') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (157'), V101 (195')) (112'-218')); DIMER (227-227'':230-230'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-DG44, IN THE PRESENCE OF 2-FLUOROFUCOSE (2FF), GLYCOFORM ALFA

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD70 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL SEA-CD70 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SEA-CD70 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CD70 (TUMOR NECROSIS FACTOR SUPERFAMILY MEMBER 7, TNFSF7, CD27LG, CD27L)), MONOCLONAL ANTIBODY (VORSETUZUMAB BETA)

VORSETUZUMAB BETA [INN]

External Clinical & Regulatory Resources

Previous UNIIY2WZ3K4VR8

Next UNIIY2X847EL2H